Middle-income countries’ healthcare sectors to keep rising through to 2024
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next…
By
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next…
ByThe global trial will evaluate two dosing regimens of rNAPc2 against heparin in hospitalised Covid-19 patients.
ICON will act as Evergreen’s CRO to aid in trial management and will conduct the medical testing activities.